Gabelli Funds’s iRadimed IRMD Stock Holding History

Gabelli Funds’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$170K	–	1154
2016 Q3	$170K	Buy	+10,000	New	+$185K	﹤0.01%	1128

Other funds holding IRMD

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gabelli Funds's IRMD Position: Q4 2016 in Review

Gabelli Funds sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 10,000 shares — an estimated $170K sold.

Gabelli Funds first reported a position in IRMD in Q3 2016 and held it in 1 quarter. The position peaked at $170K in Q3 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

Gabelli Funds reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
Gabelli Funds sold 10,000 iRadimed shares in Q4 2016, an estimated $170K.
Gabelli Funds first reported a position in iRadimed in Q3 2016 and held it in 1 quarter.
Gabelli Funds's iRadimed position peaked at $170K in Q3 2016.
58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on Gabelli Funds's 13F filing for Q4 2016, filed 10 Feb 2017.